The biotech sector's megacaps have the highest dividends

There is a low diversification of 12 months returns within the biotech sector. The sector is around 15 percent higher since April. Among the winners we find Avita Medical, Amarinoration and Shield Therapeutics. Relatively big losses are for ImmuPharma, Faron Pharmaceuticals Oy and Indivior.

Core figures biotech sector

The winners in this sector are the large caps, while smallcaps are mostly among the less performers.

Lowest PE-ratios biotech sector

Regarding the price/earnings-ratios we see a diversified palette. The large caps are with the price/earnings-ratio of 24 the most expensive. The smallcaps are the cheapest and trade at -7 times the earnings per share. Oxford BioMedica, Abcam and Bioventix are the stocks with the highest ratios. Stocks with the lowest ratios are Mallinckrodt, GenKyoTex SA and Endo International.

Highest dividend yields biotech sector

The sector's average dividend yield is with 0,7 percent relatively limited. Stocks now high dividend yields now are Biotoscana Investments SA, AbbVie and Bayer AG.

This is a free publication from Valuespectrum Pro. Valuespectrum Pro is a professional platform with analyses from all US and European companies. Click here to sign up for free.